Clinical Trials in California

Showing 8321-8340 of 8,631 trials

A Safety and Tolerability Evaluation of Two 10-Week Dose Regimens of Orally-Administered PF-04494700 in Alzheimer's Patients

NCT00141661

A 10-week safety and tolerability study of a potential treatment for mild to moderate Alzheimer's disease.

Pfizer67 participantsStarted Oct 2005

Sun City, Arizona, United States • Fresno, California, United States • San Diego, California, United States +9 more locations

COMPLETEDPhase 244 miles

Rasagiline 1 mg and 2 mg Added to Aricept 10 mg Daily in Patients With Mild to Moderate Alzheimer's Disease (AD)

NCT00104273

The purpose of this study is to evaluate the safety, tolerability, and efficacy of two dose levels of rasagiline mesylate versus placebo in patients with mild-to-moderate Alzheimer's Disease who are taking Aricept.

DementiaAlzheimer's Disease

Teva Branded Pharmaceutical Products R&D, Inc.376 participantsStarted Aug 2004

Huntsville, Alabama, United States • Huntsville, Alabama, United States • Tucson, Arizona, United States +55 more locations

A Safety and Tolerability Evaluation of Two 10-Week Dose Regimens of Orally-Administered PF-04494700 in Alzheimer's Patients

Rasagiline 1 mg and 2 mg Added to Aricept 10 mg Daily in Patients With Mild to Moderate Alzheimer's Disease (AD)

Find Trials by Condition in California

A Dose-Ranging Study of ATI 7505 in Patients With Postprandial Distress Syndrome

Duloxetine Versus Placebo for Osteoarthritis Knee Pain

Safety, Potential Efficacy, and Pharmacokinetics of PZ-601 in the Treatment of Complicated Skin and Skin Structure Infection

A Study of the Effects of 6R-BH4 on Blood Pressure in Subjects With Poorly Controlled Systemic Hypertension

Comparison of Safety and Efficacy of TOCOSOL(R) Paclitaxel Versus Taxol(R) for Treatment of Metastatic Breast Cancer

VITAL - VITamins to Slow ALzheimer's Disease (Homocysteine Study)

Oral NRX 194204 Study in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

A Dose-Finding Study Evaluating Safety and Efficacy in Patients With Chronic Obstructive Pulmonary Disease

Phase II, Randomized, Placebo-Controlled Study of ATI-7505 in Patients With Chronic Idiopathic Constipation

Study to Assess the Safety and Efficacy of NRP104 in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)

A Study to Evaluate Safety and Efficacy of PHX1149T in Subjects With Type 2 Diabetes Mellitus

Safety and Efficacy Study of Fipamezole in Treatment of Motor Dysfunctions in Parkinson's Disease

PREVENT-HF: Prevention of Heart Failure Events With Impedance Cardiography Testing

A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors

Multiple Dose Escalation Trial Of PF-04603629 Given To Subjects With Type 2 Diabetes Mellitus

A Study Of 6-Month Duration To Evaluate The Weight Loss Effect Of Various Doses Of CP-945,598 In Obese Subjects

Pemetrexed Plus Gemcitabine in Metastatic Breast Cancer Patients After Receiving Taxane Therapy

Evaluation of Neutrophil Gelatinase-associated Lipocalin (NGAL) in Early and Evolving Acute Kidney Injury